Antibodies to IL-6 and Use Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/117,861, filed Nov 25, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,935,340 | Antibodies to IL-6 and Use Thereof In force · High confidence UsedRemaining | H. Lundbeck A/S | In force | High confidence | ||
| US 8,252,286 | Antagonists of IL-6 to Prevent or Treat Thrombosis In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence | ||
| US 8,992,920 | ANTI-IL-6 Antibodies for the Treatment of Arthritis In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence | ||
| US 9,085,615 | Antibodies to IL-6 to Inhibit or Treat Inflammation In force · High confidence | H. Lundbeck A/S | In force | High confidence | ||
| US 9,468,676 | Antagonists of IL-6 to Prevent or Treat Thrombosis In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence | ||
| US 9,725,509 | Expression Vectors Containing Isolated Nucleic Acids Encoding Anti-Human IL-6 Antibody In force · Medium confidence | Vitaeris Inc. | In force | Medium confidence | ||
| US 9,834,603 | Antibodies to IL-6 and Use Thereof In force · Medium confidence | Vitaeris Inc. | In force | Medium confidence | ||
| US 9,994,635 | Antagonists of IL-6 to Raise Albumin And/Or Lower CRP In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence | ||
| US 10,160,804 | Antagonists of IL-6 to Prevent or Treat Cachexia, Weakness, Fatigue, And/Or Fever In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence | ||
| US 10,391,169 | Method of Treating Allergic Asthma with Antibodies to IL-6 In force · Medium confidence | H. Lundbeck A/S | In force | Medium confidence | ||
| 40 more records in this group · Pro | ||||||
10 of 50 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 50, including 26 expired.
12 of these are in force and held by H. Lundbeck A/S.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.